Study of 23ME-01473 in Patients With Advanced Solid Malignancies

NCT06290388 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor cancelled study

Conditions

Solid Tumor

Interventions

DRUG: 23ME-01473

Sponsor

23andMe, Inc.